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The coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is marked by one or more of symptoms: high fever, dyspnea, diarrhea, throat ache, headache, fatigue, loss of sense of taste and smell (Menni et al. [@CR7]). The diversity of clinical presentations of this disease has made it challenging for rapid clinical diagnosis. Reverse transcriptase RT-PCR coupled quantitative PCR is the only established gold standard method for definitive detection of COVID-19 by nucleic acid sequencing. Therapeutics for most viral infections, in general, are vaccines administered to trigger an immune response and thereafter remain as an immunological memory in the host immune system.

Two alternative approaches for viral infection diagnostics are possible and practiced: the first involves serological investigations for measurement of elevated biomarker levels, for example, measurement of immunoglobin M (IgM) and immunoglobin G (IgG), while the second involves direct determination of the virus itself, utilizing its unique cellular proteins. The former approach of immunosensing is limited by the concentration and half-life of the marker itself (generally host antibodies). But, in the case of acute diseases such as COVID-19, these may serve as useful pre-screening tests. The second approach involves direct detection of viruses by its cell surface proteins. For detection of newer viruses such as SARS-CoV-2, identification of unique antigen is necessary. A preliminary investigation reveals that the SARS-CoV-2 has four major structural proteins, namely the S (spike), E (envelope), M (membrane), and N (nuleocapsid) proteins (Fig. [1](#Fig1){ref-type="fig"}). Previous studies on coronaviruses including that of SARS-CoV and MERS-CoV mostly report utilization of the S1 RBD (subunit 1 receptor binding domain of S protein) and N proteins as antigens to develop detection assays. Commonly used receptors for these are antibodies (Li et al. [@CR6]), nanobodies (Zhou et al. [@CR11]), or aptamers (Ahn et al. [@CR1]).Fig. 1Structural proteins of SARS-CoV-2

Biosensors hold immense prospects in reliable and affordable diagnostic development, particularly in developing countries working with limited infrastructure, resources, and skills. The development of biosensors involves integration of three key components: the receptor, analyte--receptor interaction interface, and transduction platform. Direct determination of SARS-CoV-2 should be possible using specific receptors to the S1 RBD antigen, while detection of host immune response would involve serological investigation of IgG and IgM. Receptor--analyte interactions are generally recorded on one of optical, electrochemical, mass, acoustic or hybrid transduction platforms as an electronic readout. Our group specializes in development of optic fiber sensors which offer several advantages such as immunity to electrostatic and electromagnetic interferences, robustness, portability, and ultrasensitive detection limits for direct, label-free detection of analyte. Customized interfaces such as plasmonic gold nanoparticles, silver nanoparticles, their hybrids, and electroactive conducting polymers such as polyaniline and polypyrrole nanofibers have been utilized as effective interfaces for both immunosensing and specific analyte detection. This report explores the possible approaches of development of a point of care, low-cost evanescent wave absorbance (EWA)-based optical fiber sensor for quick and specific diagnosis of SARS-CoV-2.

EWA-Based Optical Fiber Sensor Technology {#Sec2}
=========================================

Light is propagated through an optical fiber through total internal reflection. At each such reflections at the interface, a part of the energy of the guided wave is lost to the cladding and forms an electromagnetic field called the evanescent wave. The wave is very sensitive to changes in refractive index at the interface and this property is utilized to develop EWA-based fiber optic sensors. A certain portion of the fiber is decladded to expose the core so that the evanescent wave penetrates into the surrounding medium. EWA-based optic fiber sensing systems involve use of different tapered and curved geometries of the sensing region to achieve maximal penetration depth for transduction of receptor--analyte interactions at the core-clad interface (Punjabi et al. [@CR9]). A schematic of the optic fiber sensing setup is illustrated in Fig. [2](#Fig2){ref-type="fig"}a. Light is coupled into the optical fibers from a light emitting diode (LED) and measured at the output by a suitable photodetector. Analyte--receptor interaction in the decladded (usually U-bend) region effects a localized refractive index change which is measured as a change in absorbance. This principle has been also utilized to develop highly sensitive localized surface plasmon resonance (LSPR)-based sensor, where, metal nanoparticles are immobilized on the sensor surface. Additionally, in novel interfaces such as polyaniline nanofibers, such interactions effect a localized change in charge distribution of the interface which is also utilized for biosensing.Fig. 2**a** Optical detection assembly. **b** Hand-held device developed for point of care use (reused with permission)

The EWA and LSPR technologies have been utilized for varied applications, such as, immune sensing, detection of bacteria, heavy metals (Sadani et al. [@CR10]), protein biomarkers (Khatri et al. [@CR5]), antibiotics, and bacterial susceptibility (Nag et al. [@CR8]). Such sensors have been able to detect bacteria upto 60 CFU/ml (polyaniline-coated optical fiber-based EWA sensor) and less than1000 CFU/ml (in EWA sensor) bacteria in water matrices (Bharadwaj et al. [@CR2]). Further, this has been also translated to a point of use plug and play system as demonstrated in Fig. [2](#Fig2){ref-type="fig"}b (Chandra et al. [@CR4]). The novelty of each work lies in the optimization of receptors for detection of the analyte.

Proposed Scheme for Diagnosis of SARS-CoV-2 {#Sec3}
===========================================

In response to an infection, the body initially produces IgM. This is subsequently replaced by IgG-type antibodies, which can be detected in blood days after the infections have been cleared. Thus, IgM and IgG levels in blood/ serum can be used as an indicator for exposure to SARS-CoV-2. Lateral flow assay-based tests, such as the one developed by Abbott are based on this very principle. If suitable receptors be available, biosensor cartridges can be indigenously developed and upscaled for such serological measurements in a plug and play format. Given the high sensitivity of EWA- and LSPR-based technologies, such sensors should be able to detect low concentrations of the immunoglobins, thereby reducing chances of false negatives and detection at an early stage. In an alternate approach, the antibodies for the unique S1 subunit of the S protein can be used to detect the virus itself in swab samples down to an LoD of at least 100 units/ml within an hour.

Figure [3](#Fig3){ref-type="fig"} shows the two proposed schemes for development of such sensors. Figure [3](#Fig3){ref-type="fig"}a shows antibodies immobilized on either gold nanoparticle or polyaniline-coated optical fibers for specific sensing of the virus. While Fig. [3](#Fig3){ref-type="fig"}b has specific surface proteins (of the virus) immobilized on the optical fiber for detection of IgG and/or IgM (produced as an immune response). In Scheme 3(a), the binding of virus to the antibodies would effect a localized change in the refractive index causing a change in the light intensity (absorbance) at the output. In the case of conducting polymers, this change in dielectric would cause a change in localized charge distribution, causing a change in the absorbance at the output. In the second scheme, the antigen is non-specifically captured on the optical fiber using a homo-bi-functional linker such as glutaraldehyde, or by carbodiimide--ester chemistries. Recognition of the pathogenic protein using appropriate antibodies would cause a localized refractive index change to the same effect as in the earlier case. The change in the output signal would typically be dependent on the concentration of analyte present in the sample.Fig. 3Schematic representations of the two proposed sensing schemes. **a** Direct detection of SARS-CoV-2 with immobilized antibodies. **b** Detection of IgG or IgM with immobilized specific proteins on gold nanoparticles/polyaniline nanofibers-coated optical fiber

Conclusion {#Sec4}
==========

There is tremendous scope and potential in biosensor development for detection of COVID-19. It would, however, be inappropriate to compare these with the RT-PCR-coupled qPCR methods in terms of diagnostic accuracy for two primary concerns: first, host immune responses are not precise indicators of current infection or progression of disease and second, other respiratory pathogens such as SARS-CoV or MERS might trigger similar immune responses. Direct determination of SARS-CoV-2 by its unique cell surface proteins is likely to provide more accurate results with a possible insight into the localized viral load. Biosensors could serve as useful pre-screening tests of COVID-19, particularly in countries like India. With a proven capacity of immunosensing down detection limits of 37 pM (Chandra et al. [@CR3]) and various specific analyte detections, our optic fiber platform holds tremendous prospects in COVID-19 screening.
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